Rapid and Label-Free Isolation of Tumour Cells from the Urine of Patients with Localised Prostate Cancer Using Inertial Microfluidics

During the last decade, isolation of circulating tumour cells via blood liquid biopsy of prostate cancer (PCa) has attracted significant attention as an alternative, or substitute, to conventional diagnostic tests. However, it was previously determined that localised forms of PCa shed a small number of cancer cells into the bloodstream, and a large volume of blood is required just for a single test, which is impractical. To address this issue, urine has been used as an alternative to blood for liquid biopsy as a truly non-invasive, patient-friendly test. To this end, we developed a spiral microfluidic chip capable of isolating PCa cells from the urine of PCa patients. Potential clinical utility of the chip was demonstrated using anti-Glypican-1 (GPC-1) antibody as a model of the primary antibody in immunofluorescent assay for identification and detection of the collected tumour cells. The microchannel device was first evaluated using DU-145 cells in a diluted Dulbecco’s phosphate-buffered saline sample, where it demonstrated >85 (±6) % efficiency. The microchannel proved to be functional in at least 79% of cases for capturing GPC1+ putative tumour cells from the urine of patients with localised PCa. More importantly, a correlation was found between the amount of the captured GPC1+ cells and crucial diagnostic and prognostic parameter of localised PCa—Gleason score. Thus, the technique demonstrated promise for further assessment of its diagnostic value in PCa detection, diagnosis, and prognosis.

[1]  Jongyoon Han,et al.  Ultra-fast, label-free isolation of circulating tumor cells from blood using spiral microfluidics , 2015, Nature Protocols.

[2]  I. Thompson,et al.  Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification. , 2006, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[3]  Peter C. Y. Chen,et al.  Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells. , 2014, Lab on a chip.

[4]  Mohsen Asadnia,et al.  Selective separation of microalgae cells using inertial microfluidics. , 2018, Bioresource technology.

[5]  Peter Hoffmann,et al.  Rapid separation and identification of beer spoilage bacteria by inertial microfluidics and MALDI-TOF mass spectrometry. , 2019, Lab on a chip.

[6]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[7]  Colleen Nelson,et al.  Enrichment of circulating head and neck tumour cells using spiral microfluidic technology , 2017, Scientific Reports.

[8]  B. Bai,et al.  The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer , 2019, Front. Oncol..

[9]  S. Srivastava,et al.  Prostate cancer marker panel with single cell sensitivity in urine , 2015, The Prostate.

[10]  Majid Ebrahimi Warkiani,et al.  Multiplexing slanted spiral microchannels for ultra-fast blood plasma separation. , 2016, Lab on a chip.

[11]  H. Scher,et al.  Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility. , 2019, Clinical chemistry.

[12]  Yoon‐Kyoung Cho,et al.  Urine-based liquid biopsy: non-invasive and sensitive AR-V7 detection in urinary EVs from patients with prostate cancer. , 2018, Lab on a chip.

[13]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[14]  C. Lim,et al.  Malaria detection using inertial microfluidics. , 2015, Lab on a chip.

[15]  D. Jin,et al.  Rapid Softlithography Using 3D‐Printed Molds , 2019, Advanced Materials Technologies.

[16]  M. Frydenberg,et al.  Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer , 2018, PloS one.

[17]  T. Nagy,et al.  Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth , 2019, Scientific Reports.

[18]  N. Vandemark,et al.  The Male Reproductive System , 2004, The Quick and the Dead.

[19]  Benjamin Thierry,et al.  Isolation of Circulating Fetal Trophoblasts Using Inertial Microfluidics for Noninvasive Prenatal Testing , 2018, Advanced Materials Technologies.

[20]  Sharanjot Saini PSA and beyond: alternative prostate cancer biomarkers , 2016, Cellular Oncology.

[21]  James E. Verdone,et al.  Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer , 2017, Nature Reviews Urology.

[22]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[23]  Nam-Trung Nguyen,et al.  Fundamentals and applications of inertial microfluidics: a review. , 2016, Lab on a chip.

[24]  Ali Asgar S. Bhagat,et al.  Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells , 2014, PloS one.

[25]  Timothy J Wilt,et al.  Prevention and early detection of prostate cancer. , 2014, The Lancet. Oncology.